Dexfenfluramine is indicated for the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet. Dexfenfluramine hydrochloride is recommended for obese patients with an initial body mass index ³30 kg/m2, or ³27 kg/m2 in the presence of other risk factors (e.g., hypertension, diabetes, hyperlipidemia).
The safety and effectiveness of dexfenfluramine beyond 1 year have not been determined at this time.
Below is a chart of Body Mas...
Read the complete drug monograph for Redux »